Quantum BioPharma Signs Binding Letter Of Intent With Allucent To Conduct Phase 2 Clinical Trial In Multiple Sclerosis
Go back to Quantum BioPharma Signs Binding Letter Of Intent With Allucent To Conduct Phase 2 Clinical Trial In Multiple Sclerosis| Quantum Technology Corp (NASDAQ: QNTM) | Delayed: 3.80 -0.13 (3.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.93 | 52 Week High | $2.00 | |||
| Open | $3.93 | 52 Week Low | $0.10 | |||
| Day High | $4.01 | P/E | N/A | |||
| Day Low | $3.64 | EPS | $0.00 | |||
| Volume | 104,356 | |||||
